Therapies Offered at Residential Addiction Treatment Programs in the United States

JAMA. 2020 Aug 25;324(8):804-806. doi: 10.1001/jama.2020.8969.


This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.

MeSH terms

  • Analgesics, Opioid / therapeutic use*
  • Behavior Therapy*
  • Behavior, Addictive / therapy
  • Health Care Surveys
  • Humans
  • Opioid-Related Disorders / drug therapy
  • Opioid-Related Disorders / rehabilitation
  • Opioid-Related Disorders / therapy*
  • Residential Treatment*
  • United States


  • Analgesics, Opioid